Insulin Requirements and Carbohydrate to Insulin Ratio in Normal Weight, Overweight, and Obese Women With Type 1 Diabetes Under Pump Treatment During Pregnancy: A Lesson From Old Technologies.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2021
Historique:
received: 27 09 2020
accepted: 14 01 2021
entrez: 18 3 2021
pubmed: 19 3 2021
medline: 21 12 2021
Statut: epublish

Résumé

The primary aim of this study was to assess insulin requirements and carbohydrate to insulin ratio (CHO/IR) in normal weight, overweight, and obese pregnant women with type 1 diabetes across early, middle, and late pregnancy. In this multicenter, retrospective, observational study we evaluated 86 of 101 pregnant Caucasian women with type 1 diabetes under pump treatment. The women were trained to calculate CHO/IR daily by dividing CHO grams of every single meal by insulin units injected. Since the purpose of the study was to identify the CHO/IR able to reach the glycemic target, we only selected the CHO/IR obtained when glycemic values were at target. Statistics: SPSS 20. We studied 45 normal weight, 31 overweight, and 10 obese women. Insulin requirements increased throughout pregnancy (p < 0.0001 and <0.001 respectively) in the normal and overweight women, while it remained unchanged in the obese women. Insulin requirements were different between groups when expressed as an absolute value, but not when adjusted for body weight. Breakfast CHO/IR decreased progressively throughout pregnancy in the normal weight women, from 13.3 (9.8-6.7) at the first stage of pregnancy to 6.2 (3.8-8.6) (p = 0.01) at the end stage, and in the overweight women from 8.5 (7.1-12.6) to 5.2 (4.0-8.1) (p = 0.001), while in the obese women it remained stable, moving from 6.0 (5.0-7.9) to 5.1 (4.1-7.4) (p = 0.7). Likewise, lunch and dinner CHO/IR decreased in the normal weight and overweight women (p < 0.03) and not in the obese women. The obese women gained less weight than the others, especially in early pregnancy when they even lost a median of 1.25 (-1 -1.1) kg (p = 0.005). In early pregnancy, we found a correlation between pregestational BMI and insulin requirements (IU/day) or CHO/IR at each meal (p < 0.001 and p = 0.001, respectively). In late pregnancy, a relationship between pre-gestational BMI and CHO/IR change was found (P = 0.004), as well as between weight gain and CHO/IR change (p=0.02). The significance was lost when both variables were included in the multiple regression analysis. There was no difference in pregnancy outcomes except for a higher pre-term delivery rate in the obese women. Pre-gestational BMI and weight gain may play a role in determining CHO/IR during pregnancy in women with type 1 diabetes under pump treatment.

Identifiants

pubmed: 33732212
doi: 10.3389/fendo.2021.610877
pmc: PMC7959706
doi:

Substances chimiques

Dietary Carbohydrates 0
Insulin 0

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

610877

Informations de copyright

Copyright © 2021 Festa, Fresa, Visalli, Bitterman, Giuliani, Suraci, Bongiovanni and Napoli.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

JAMA. 2013 Jun 12;309(22):2362-70
pubmed: 23757084
Diabetologia. 2012 Feb;55(2):282-93
pubmed: 22080230
Diabetes Care. 2010 Feb;33(2):356-60
pubmed: 19880583
Diabetologia. 2016 Jun;59(6):1089-94
pubmed: 26995651
Diabetes Care. 2014 Jun;37(6):e121-2
pubmed: 24855162
J Diabetes Sci Technol. 2010 Sep 01;4(5):1174-81
pubmed: 20920437
Nutr Metab Cardiovasc Dis. 2019 Feb;29(2):115-126
pubmed: 30642790
Diabetes Technol Ther. 2017 May;19(5):280-287
pubmed: 28282241
Diabetol Int. 2018 Aug 21;10(2):102-108
pubmed: 31139528
J Matern Fetal Neonatal Med. 2010 Nov;23(11):1310-4
pubmed: 20334531
Am J Obstet Gynecol. 1998 Jul;179(1):156-65
pubmed: 9704782
Eur J Pediatr. 2011 Jul;170(7):891-8
pubmed: 21140273
Diabetologia. 2010 Mar;53(3):446-51
pubmed: 20013109
Br J Obstet Gynaecol. 1981 Oct;88(10):961-7
pubmed: 7025884
BMJ. 2017 Feb 8;356:j1
pubmed: 28179267
Am J Obstet Gynecol. 1988 Sep;159(3):616-21
pubmed: 3048099
Diabet Med. 2019 Aug;36(8):1037-1045
pubmed: 31087451
Diabetes Care. 2004 Jan;27 Suppl 1:S76-8
pubmed: 14693933
JAMA. 1991 Feb 13;265(6):731-6
pubmed: 1990188
Diabetologia. 2012 Sep;55(9):2327-34
pubmed: 22752076
Diabetes Care. 2018 Dec;41(12):2471-2479
pubmed: 30327362
Diabetologia. 2015 Nov;58(11):2615-26
pubmed: 26248646
Diabetes Care. 2013 Oct;36(10):3162-8
pubmed: 23835692
Acta Diabetol. 2013 Dec;50(6):959-64
pubmed: 23778883
Am J Obstet Gynecol. 2012 Oct;207(4):324.e1-5
pubmed: 23021699
Diabetes Care. 2009 Nov;32(11):2005-9
pubmed: 19675195
Diabetes Care. 2004 Jan;27 Suppl 1:S110
pubmed: 14693943
Endocr Pract. 2008 Dec;14(9):1095-101
pubmed: 19158048
Metabolism. 2015 Dec;64(12):1629-39
pubmed: 26455399
Diabetes Care. 2012 Jun;35(6):1246-8
pubmed: 22432115
Nutr Metab Cardiovasc Dis. 2008 May;18(4):291-7
pubmed: 17433638
J Matern Fetal Neonatal Med. 2014 May;27(7):724-8
pubmed: 23981186
BMJ. 2002 Oct 5;325(7367):746
pubmed: 12364302
Diabetes Technol Ther. 2016 Jun;18(6):360-5
pubmed: 27028951
Ann Nutr Metab. 2017;70(2):140-146
pubmed: 28391275

Auteurs

Camilla Festa (C)

Department of Clinical and Molecular Medicine Sapienza University of Rome, Rome, Italy.

Raffaella Fresa (R)

Azienda Sanitaria Locale Salerno, Salerno, Italy.

Natalia Visalli (N)

Santo Spirito Hospital, Pescara, Italy.

Olimpia Bitterman (O)

Department of Clinical and Molecular Medicine Sapienza University of Rome, Rome, Italy.
Department of Experimental Medicine Sapienza University of Rome, Rome, Italy.

Chiara Giuliani (C)

Department of Clinical and Molecular Medicine Sapienza University of Rome, Rome, Italy.
Department of Experimental Medicine Sapienza University of Rome, Rome, Italy.

Concetta Suraci (C)

Department of Experimental Medicine Sapienza University of Rome, Rome, Italy.
Policlinico Casilino, Rome, Italy.

Marzia Bongiovanni (M)

Policlinico Casilino, Rome, Italy.
Ospedale Israelitico, Rome, Italy.

Angela Napoli (A)

Department of Clinical and Molecular Medicine Sapienza University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH